Rac GTPase-activating protein
From Proteopedia
(Difference between revisions)
(New page: <StructureSection load='5c2j' size='340' side='right' caption='Caption for this structure' scene=''> == Function == '''Rac GTPase-activating protein 1''' (RACGAP1) is required for the at...) |
|||
Line 1: | Line 1: | ||
- | + | <StructureSection load='5c2j' size='340' side='right' caption='Human Rac GTPase-activating protein 1 GAP domain (grey) complex with CDC42 (green) and GDP (PDB code [[5c2j]])' scene=''> | |
- | <StructureSection load='5c2j' size='340' side='right' caption=' | + | |
== Function == | == Function == | ||
- | '''Rac GTPase-activating protein 1''' ( | + | '''Rac GTPase-activating protein 1''' (RacGAP1) is required for the attachment of the midbody to the cell membrane during cytokinesis. It is involved in the regulation of growth-related processes in adipocytes and myoblasts. |
- | + | ||
== Relevance == | == Relevance == | ||
- | + | RacGAP1 expression is a prognostic marker for HBV-positive human hepatocellular carcinoma and can be a potential molecular target for therapeutic strategies against this carcinoma<ref>PMID:21825042</ref>. | |
- | + | ||
- | + | ||
Revision as of 09:11, 12 February 2017
|
3D structures of Rac GTPase-activating protein 1
Updated on 12-February-2017
References
- ↑ Wang SM, Ooi LL, Hui KM. Upregulation of Rac GTPase-activating protein 1 is significantly associated with the early recurrence of human hepatocellular carcinoma. Clin Cancer Res. 2011 Sep 15;17(18):6040-51. doi: 10.1158/1078-0432.CCR-11-0557. , Epub 2011 Aug 8. PMID:21825042 doi:http://dx.doi.org/10.1158/1078-0432.CCR-11-0557